Selective serotonin re-uptake inhibitors in anorexia nervosa

Meera Vaswani, Harish Kalra

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Anorexia nervosa (AN), one of the major eating disorders, is a primarily psychiatric illness affecting a number of adolescents and young adults. AN usually runs a chronic course and is associated with significant morbidity and mortality. Drug therapy has modest success in its treatment. Various pharmacotherapeutic agents are being tested, with variable success. Selective serotonin re-uptake inhibitors are the one class of drug that has been found to be effective in AN, especially in preventing relapse. This article provides an overview of the current literature on the role of selective serotonin re-uptake inhibitors in the treatment of AN. 2004

Original languageEnglish (US)
Pages (from-to)349-357
Number of pages9
JournalExpert Opinion on Investigational Drugs
Issue number4
StatePublished - Apr 2004
Externally publishedYes


  • Anorexia nervosa
  • Pharmacotherapy
  • Selective serotonin re-uptake inhibitors
  • Serotonin


Dive into the research topics of 'Selective serotonin re-uptake inhibitors in anorexia nervosa'. Together they form a unique fingerprint.

Cite this